Sign In
3 Apr 2009 07:00
3 April 2009
Imaginatik Plc
("Imaginatik" or the "Company")
Contract Win & Trading Update
Imaginatik plc (AIM: IMTK), a leading provider of cost reduction, process improvement and collaborative innovation software and processes, is pleased to announce it has signed a significant contract extension with Pfizer, Inc., a long-standing customer of Imaginatik’s and investor in the Company. This contract extension ensures the long term ongoing use of Imaginatik’s Idea Central software within Pfizer’s Research and Development division.
Imaginatik expects to announce Final Results for the year ended 31st March 2009 in line with market expectations.
Mark Turrell, CEO of Imaginatik plc, commented, "The past 12 months has been a key period in the development of Imaginatik. It has seen the Company mature into a more stable and well managed business with an increasing ability to secure longer term contracts resulting in much greater certainty in earnings going forward. We are delighted to report that, in line with market expectations, we expect this maturity to translate into a maiden operating profit for the year."
For further information please contact:
|
Imaginatik plc |
Tel: 020 7917 2975 |
|
Mark Turrell, CEO / Shawn Taylor, CFO |
|
|
WH Ireland Limited |
Tel: 0121 265 6330 |
|
Tim Cofman / Katy Birkin |
|
|
ICIS |
Tel: 020 7651 8688 |
|
Caroline Evans-Jones / Mike Smith |
About Imaginatik
Imaginatik is the leading provider of cost reduction, process improvement and collaborative innovation software and processes to the world's leading companies. More than 100 clients rely on Imaginatik's software, consulting and research to enable their best-of-breed innovation activities.
Named as a World Economic Forum Technology Pioneer for 2008 and a finalist for the IBM Lotus Awards 2008 in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings, process improvements and increased product pipeline. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as the London Business School and the Cass School of Business, London, as well as leading practitioners of corporate innovation.
For further information please visit www.imaginatik.com
Follow the stocks
